Guangdong Kangcheng Pharmaceutical

Guangdong Kangcheng Pharmaceutical is a Chinese pharmaceutical company focused on the development, manufacturing, and commercialization of chemical drugs and traditional Chinese medicine (TCM). The company maintains a specialized focus on respiratory and cardiovascular health, offering a portfolio that includes cough syrups, anti-viral agents, and gastrointestinal treatments. Headquartered in Shantou and listed on China's National Equities Exchange and Quotations (NEEQ: 833215), the firm operates GMP-certified manufacturing facilities and a dedicated research institute for drug engineering. Their commercial catalog features well-known generic medications such as Entecavir for hepatitis B and Rosuvastatin for cholesterol management. Kangcheng emphasizes the modernization of traditional Chinese patent medicines and serves a broad domestic market through an established provincial distribution network.